<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Vasopressin lowers renal epoxyeicosatrienoic acid levels by activating soluble epoxide hydrolase</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Christin</forename><surname>Boldt</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anatomy</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Tom</forename><surname>Röschel</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anatomy</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Nina</forename><surname>Himmerkus</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Physiology</orgName>
								<orgName type="institution">Christian-Albrechts-University</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Allein</forename><surname>Plain</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Physiology</orgName>
								<orgName type="institution">Christian-Albrechts-University</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Markus</forename><surname>Bleich</surname></persName>
							<affiliation key="aff1">
								<orgName type="department">Department of Physiology</orgName>
								<orgName type="institution">Christian-Albrechts-University</orgName>
								<address>
									<settlement>Kiel</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Robert</forename><surname>Labes</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anatomy</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Maximilian</forename><surname>Blum</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Max Delbrueck Center for Molecular Medicine</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hans</forename><surname>Krause</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Ahmed</forename><surname>Magheli</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">Department of Urology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Torsten</forename><surname>Giesecke</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anatomy</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Kerim</forename><surname>Mutig</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anatomy</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Michael</forename><surname>Rothe</surname></persName>
							<affiliation key="aff4">
								<address>
									<settlement>Lipidomix, Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Steven</forename><forename type="middle">M</forename><surname>Weldon</surname></persName>
							<affiliation key="aff5">
								<orgName type="institution">Boehringer Ingelheim Pharmaceuticals</orgName>
								<address>
									<settlement>Ridgefield, Connecticut</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Duska</forename><surname>Dragun</surname></persName>
							<affiliation key="aff6">
								<orgName type="department">Department of Nephrology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="institution">Berlin Institute of Health</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Wolf-Hagen</forename><surname>Schunck</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Max Delbrueck Center for Molecular Medicine</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Sebastian</forename><surname>Bachmann</surname></persName>
							<affiliation key="aff0">
								<orgName type="department">Department of Anatomy</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author role="corresp">
							<persName><forename type="first">Alexander</forename><surname>Paliege</surname></persName>
							<email>alexander.paliege@charite.de</email>
							<affiliation key="aff6">
								<orgName type="department">Department of Nephrology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="institution">Berlin Institute of Health</orgName>
								<address>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff8">
								<orgName type="department">Dept. of Nephrology</orgName>
								<orgName type="institution">Charité-Universitätsmedizin Berlin</orgName>
								<address>
									<addrLine>Philippstr. 12</addrLine>
									<postCode>D-10115</postCode>
									<settlement>Berlin</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Vasopressin lowers renal epoxyeicosatrienoic acid levels by activating soluble epoxide hydrolase</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">88761E84904FDF137A7BCC041C1BE389</idno>
					<idno type="DOI">10.1152/ajprenal.00062.2016</idno>
					<note type="submission">Submitted 29 January 2016; accepted in final form 19 September 2016</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:48+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Activation of the thick ascending limb (TAL) Na ϩ -K ϩ -2Cl Ϫ cotransporter (NKCC2) by the antidiuretic hormone arginine vasopressin (AVP) is an essential mechanism of renal urine concentration and contributes to extracellular fluid and electrolyte homeostasis.</s><s>AVP effects in the kidney are modulated by locally and/or by systemically produced epoxyeicosatrienoic acid derivates (EET).</s><s>The relation between AVP and EET metabolism has not been determined.</s><s>Here, we show that chronic treatment of AVP-deficient Brattleboro rats with the AVP V2 receptor analog desmopressin (dDAVP; 5 ng/h, 3 days) significantly lowered renal EET levels (Ϫ56 Ϯ 3% for 5,6-EET, Ϫ50 Ϯ 3.4% for 11,12-EET, and Ϫ60 Ϯ 3.7% for 14,15-EET).</s><s>The abundance of the principal EET-degrading enzyme soluble epoxide hydrolase (sEH) was increased at the mRNA (ϩ160 Ϯ 37%) and protein levels (ϩ120 Ϯ 26%).</s><s>Immunohistochemistry revealed dDAVP-mediated induction of sEH in connecting tubules and cortical and medullary collecting ducts, suggesting a role of these segments in the regulation of local interstitial EET signals.</s><s>Incubation of murine kidney cell suspensions with 1 M 14,15-EET for 30 min reduced phosphorylation of NKCC2 at the AVPsensitive threonine residues T96 and T101 (Ϫ66 Ϯ 5%; P Ͻ 0.05), while 14,15-DHET had no effect.</s><s>Concomitantly, isolated perfused cortical thick ascending limb pretreated with 14,15-EET showed a 30% lower transport current under high and a 70% lower transport current under low symmetric chloride concentrations.</s><s>In summary, we have shown that activation of AVP signaling stimulates renal sEH biosynthesis and enzyme activity.</s><s>The resulting reduction of EET tissue levels may be instrumental for increased NKCC2 transport activity during AVP-induced antidiuresis.</s><s>urine concentration mechanism; thick ascending limb; NKCC2 WATER CONSERVATION BY THE mammalian kidney is achieved by the tightly controlled, coordinate action of epithelial and vascular components.</s><s>The hypothalamic antidiuretic hormone (arginine vasopressin, AVP) plays a dominant role herein.</s><s>It</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>stimulates luminal insertion of water channels along the connecting tubule and collecting duct epithelia, as well as the insertion of urea transporters into medullary portion of the collecting duct <ref type="bibr" target="#b36">(37)</ref>.</s><s>The thick ascending limb (TAL) is sensitive to AVP as well, since abundance, phosphorylation, and surface expression of the furosemide sensitive Na ϩ -K ϩ -2Cl Ϫ cotransporter (NKCC2) are stimulated by the hormone <ref type="bibr" target="#b36">(37)</ref>.</s><s>At the vascular level, AVP causes vasoconstriction of preglomerular arterioles and descending vasa recta and, thereby, reduces medullary blood flow.</s><s>The combination of an augmented solute transport activity and a reduced perfusion facilitates efficient countercurrent multiplication but also results in a marked hypoxia of key medullary structures <ref type="bibr" target="#b16">(17)</ref>, which may promote the development of renal disease <ref type="bibr" target="#b4">(5)</ref>.</s><s>The renal effects of AVP are modulated by locally produced arachidonic acid derivates such as 20-hydroxyeicosatetraenoic acid (20-HETE), epoxyeicosatrienoic acid (EET), and prostaglandin E 2 (PGE 2 ) which inhibit TAL transport activity <ref type="bibr" target="#b0">(1,</ref><ref type="bibr" target="#b14">15,</ref><ref type="bibr" target="#b25">26,</ref><ref type="bibr" target="#b30">31,</ref><ref type="bibr" target="#b57">57)</ref> and increase medullary perfusion <ref type="bibr" target="#b3">(4,</ref><ref type="bibr" target="#b73">74)</ref>.</s><s>While the regulation of 20-HETE and PGE 2 during AVP-induced antidiuresis has been studied in considerable detail <ref type="bibr" target="#b59">(59,</ref><ref type="bibr" target="#b72">73,</ref><ref type="bibr" target="#b76">77)</ref>, less is known regarding the mechanisms that determine synthesis and metabolism of EET in this setting.</s><s>EETs exist as four regioisomers: 5,6-EET, 8,9-EET, 11,12-EET, and 14,15-EET, which are synthesized by the cytochrome P-450 (CYP450) monooxygenases <ref type="bibr" target="#b17">(18,</ref><ref type="bibr" target="#b57">57)</ref>.</s><s>CYP450 isoforms 2C9/10, 2C11, 2C23, 2J3, and 2J4 have all been shown to contribute to renal EET synthesis <ref type="bibr" target="#b17">(18,</ref><ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b33">34)</ref>.</s><s>In rats, 2C23 is considered the principal renal isoform to generate EET in rat kidney <ref type="bibr" target="#b33">(34)</ref>.</s><s>EETs are metabolically degraded mainly by soluble epoxide hydrolase (sEH), which hydrolyzes EET to their corresponding, less active dihydroxyeicosatrienoic acid isomers (DHETs) <ref type="bibr" target="#b30">(31,</ref><ref type="bibr" target="#b57">57)</ref>.</s><s>The preferred substrates for sEH are 14,15-EET, 11,12-EET, and 8,9-EET, whereas the affinity of the enzyme toward 5,6-EET is low <ref type="bibr" target="#b29">(30)</ref>.</s><s>The kidney shows substantial sEH activity, but the site of its synthesis and regulation within the renal parenchyma has not been unequivocally clarified <ref type="bibr" target="#b18">(19,</ref><ref type="bibr" target="#b32">33,</ref><ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b47">48,</ref><ref type="bibr" target="#b74">75)</ref>.</s><s>Earlier, microarray-based gene expression studies have provided evidence for AVP-dependent activation of sEH in the kidney <ref type="bibr" target="#b16">(17,</ref><ref type="bibr" target="#b50">51)</ref>, prompting us to study the effects of AVP on renal medullary EET metabolism in greater detail.</s></p><p><s>In the present study, we found that sEH is abundantly expressed in the segments of human and rat nephrons and collecting duct system.</s><s>Chronic AVP treatment induced sEH biosynthesis in AVP-deficient Brattleboro rats, which was associated with a reduction of renal EET levels.</s><s>Functional studies in isolated TAL segments demonstrated an inhibitory effect of 14,15-EET on NKCC2 phosphorylation and transport activity.</s><s>Induction of sEH by AVP may, therefore, be an essential mechanism for the maintenance of sustained antidiuresis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>MATERIALS AND METHODS</head><p><s>Animal studies and tissue preservation.</s><s>Animal studies were performed according to National Institutes of Health's guidelines after approval from the Berlin Council on Animal Care (permission numbers G006-02/05, G0285/10, and O0124/96).</s><s>For localization studies, adult Sprague-Dawley (SD) rats (n ϭ 3) were perfusion-fixed via the abdominal aorta, using a fixative containing 3% paraformaldehyde (Merck, Darmstadt, Germany) dissolved in PBS, as previously described <ref type="bibr" target="#b51">(52)</ref>.</s><s>Kidneys were harvested and processed for cryostat and paraffin sectioning using established methodology <ref type="bibr" target="#b50">(51)</ref>.</s><s>For Western blot analysis of zonal sEH distribution, additional SD rats (n ϭ 3) were killed by cervical dislocation.</s><s>Kidneys were carefully removed and dissected into cortex, outer medulla, and inner medulla using sterile razor blades and a stereotactic microscope.</s><s>Samples were subsequently snap frozen in liquid nitrogen, and stored at Ϫ80°C until further use.</s><s>Human kidney samples (n ϭ 3) were obtained from the healthy parts of tumor nephrectomy specimen after written consent of the patients.</s><s>Tissue blocks were immersion-fixed for 12 h using 3% paraformaldehyde in PBS and subsequently processed for paraffin embedding <ref type="bibr" target="#b45">(46)</ref>.</s><s>Detailed protocols for treatment of Brattleboro rats with 1-desamino-8-D-Arg vasopressin (dDAVP) have been published before <ref type="bibr" target="#b50">(51)</ref>.</s><s>Briefly, Brattleboro rats aged 2-3 mo (n ϭ 26) were treated with normal saline as vehicle or dDAVP (n ϭ 13 each; 5 ng/h for 3 days; Sigma Aldrich, Munich, Germany) via subcutaneous infusion using osmotic minipumps (ALZET osmotic minipump, model 2001; Charles River, Sulzfeld, Germany).</s><s>At the end of the treatment period, animals for microarray (n ϭ 3 per group) and biochemical studies (n ϭ 5 per group) were killed by cervical dislocation.</s><s>Kidneys were carefully removed and processed at 4°C.</s><s>Samples were snap frozen in liquid nitrogen, and stored at Ϫ80°C until further use.</s><s>Animals for morphological studies (n ϭ 5 per group) were perfusion fixed as detailed above.</s><s>sEH-deficient mice were originally obtained from Boehringer Ingelheim Pharmaceutical (Ridgefield, CT) and bred in the animal facility of the Max Delbrück Center for Molecular Medicine in Berlin.</s><s>A detailed description for the establishment of gene deletion and genotyping has been published <ref type="bibr" target="#b40">(41,</ref><ref type="bibr">62)</ref>.</s><s>Animals were back-crossed into FVB/N background for at least six generations <ref type="bibr" target="#b27">(28)</ref>.</s><s>At 3 mo of age, kidneys of male knockout and wild-type mice (n ϭ 4 for each genotype) were harvested for biochemical analysis or fixed overnight using 3% paraformaldehyde in PBS and processed for histological studies.</s><s>Microdissection of murine TAL segments was performed as previously described (9) using a total of six male C57/BL6 mice (Charles River, Sulzfeld, Germany).</s></p><p><s>Microarray studies.</s><s>Gene expression profiling studies were conducted in the microarray facility at the Zentrum für Medizinische Forschung of the University Mannheim (Mannheim, Germany), as previously described <ref type="bibr" target="#b16">(17,</ref><ref type="bibr" target="#b50">51)</ref>.</s><s>Affymetrix rat genome 230 2.0 arrays and a custom CDF version 9 annotation with Unigene-based gene definitions (http://brainarray.mbni.med.umich.edu/Brainarray/Database/CustomCDF/CDF_download_v9.asp) were used for the analysis.</s><s>Raw and normalized data were deposited in the Gene Expression Omnibus database (http://www.ncbi.nlm.nih.gov/geo/;</s><s>GEO accession number: GSE34225).</s></p><p><s>Quantification of renal outer medullary lipid levels.</s><s>Free tissue lipid levels were determined by mass spectrometry in kidney samples of dDAVP-treated Brattleboro rats and controls.</s><s>Samples were powdered in liquid nitrogen, dissolved in a 50/50 vol/vol mixture of water and methanol supplemented with 0.01% butylhydroxytoluol, mixed with 10 l internal standard solution (0.5 g/ml), and buffered at pH 6 with 2 ml SPE-buffer (0.1 mol/l aqueous sodium acetate solution, pH 6).</s><s>Solid-phase extraction was performed using a Bond-Elut-Certify-II-Column (Phenomenex, Torrance, CA).</s><s>Eicosanoids were eluted with 2 ml n-hexane/ethylacetate (25/75 vol/vol) with 1% acetic acid.</s><s>The solvent was evaporated with a gentle stream of N 2 at 40°C.</s><s>Residues were resuspended in 100 l methanol/water mixture and processed for measuring.</s><s>Liquid chromatography-mass spectrometry (LC-MS/MS) was performed at the mass spectrometry facility of Lipidomix, as previously described (Lipidomix, Berlin, Germany) <ref type="bibr" target="#b1">(2)</ref>.</s><s>Free tissue levels of EET isomers and of the linoleic acid epoxides 9,10-EPOME and 12,13-EPOME and their respective diols 9,10-DIHOME and 12,13-DIHOME were determined in parallel.</s><s>Since the formation of these diols is also catalyzed by sEH, the ratio of DIHOME and EPOME isomers can be used as a measure for sEH tissue activity <ref type="bibr" target="#b19">(20,</ref><ref type="bibr" target="#b67">68)</ref>.</s></p><p><s>Real-time PCR.</s><s>mRNA was isolated from whole kidney homogenates using Roti-Aqua phenol-chloroform extraction kit, according to the manufacturer's protocol (Carl Roth, Karlsruhe, Germany).</s><s>After digestion of genomic DNA by DNase 1 treatment (Qiagen, Hilden, Germany) cDNA was generated by reverse transcription using the Applied Biosystems cDNA synthesis kit (Applied Biosystems, Darmstadt, Germany).</s><s>TaqMan quantitative RT-PCR for sEH was performed using the Applied Biosystems probe Mm00514706 and the 7500 Fast real-time PCR system (Applied Biosystems) following the manufacturer's instructions.</s><s>The mRNA levels of GAPDH were determined in parallel and served as a loading control (catalog no.</s><s>4352338E; Applied Biosystems).</s><s>Expression levels were calculated using the 2 Ϫ⌬⌬CT method and were expressed as a percentage of control <ref type="bibr" target="#b39">(40)</ref>.</s></p><p><s>Primary antibodies.</s><s>For detection of sEH, we used an Affinitypurified rabbit antibody against human sEH (1:500, HPA023094; Atlas Antibodies, Stockholm, Sweden).</s><s>Antibodies against total and phospho-(p)-T96/T101-NKCC2 were generated in our laboratory and have been described before <ref type="bibr" target="#b45">(46)</ref>.</s><s>Antibodies for cyclooxygenase 2 (COX-2; sc-1746) and aquaporin 2 (AQP2; sc-9882) were obtained from Santa Cruz Biotechnology (Dallas, TX).</s><s>Antibody against the Na ϩ -Cl Ϫ -cotransporter NCC was provided by D. Ellison (Oregon Health &amp; Science University, Portland, OR) and served as a marker for the distal convoluted tubule <ref type="bibr" target="#b50">(51)</ref>.</s><s>Antibody for the proximal tubule marker megalin was a kind gift of T. Willnow (MDC, Berlin, Germany) and has been described before <ref type="bibr" target="#b2">(3)</ref>.</s><s>The antibody against mouse ␣-smooth muscle actin was obtained from DAKO (Hamburg, Germany); the antibody for ␤-actin was obtained from Sigma-Aldrich.</s></p><p><s>Immunoblotting.</s><s>Samples for Western blot analysis were prepared as previously described <ref type="bibr" target="#b70">(71)</ref>.</s><s>Briefly, tissues were ground in liquid nitrogen using sterile mortar and pestle and subsequently dissolved in homogenization buffer containing 250 mM sucrose, 10 mM triethanolamine, and protease inhibitors (cOmplete protease inhibitor cocktail; Roche Diagnostics, Indianapolis, IN).</s><s>Nuclei were removed by centrifugation (1,000 g for 10 min).</s><s>Protein concentration of postnuclear homogenates was determined using bicinchoninic acid protein assay following the manufacturer's instructions (ThermoFisher Scientific, Bonn, Germany).</s><s>Samples were subsequently separated by SDS-PAGE in a 10% gel (50 g protein/lane) and electrophoretically transferred to nitrocellulose membranes.</s><s>Primary antibodies were applied after blocking of nonspecific protein binding sites with 5% nonfat dry milk in PBS.</s><s>Membranes were incubated for 1 h at room temperature followed by an overnight incubation at 4°C.</s><s>Bound antibody was detected using the appropriate HRP-conjugated secondary antibodies and chemiluminescence.</s><s>Developed X-ray films were scanned and densitometrically evaluated using the Alpha Imager software (Cell Biosci-ences, Santa Clara, CA).</s><s>Expression levels were normalized to the expression of the housekeeping gene ␤-actin.</s></p><p><s>Immunostaining.</s><s>Immunofluorescence and immunoperoxidase staining were carried out as previously described <ref type="bibr" target="#b50">(51)</ref>.</s><s>Briefly, 4-m paraffin sections were deparaffinized, rehydrated, and subjected to antigen retrieval by boiling in 0.1 M sodium citrate buffer using a pressure cooker.</s><s>Nonspecific binding sites were blocked by incubation with 5% dry milk in PBS.</s><s>Renal localization of sEH was studied by immunofluorescence staining on 4-m paraffin sections of human and rat kidneys using the rabbit anti-sEH antibody in a 1:100 dilution.</s><s>Immunoreactive nephron segments were characterized by double labeling with the established segment-specific antibodies to NKCC2 (1:5,000 dilution) for TAL, COX-2 (1:100 dilution) for macula densa, NCC (1:100 dilution) for distal convoluted tubule, and AQP2 (1:100 dilution) for connecting tubule and collecting duct, respectively.</s><s>Bound antibodies were detected with the appropriate Alexa Fluor 488 or Cy3-labeled secondary antibodies (Dianova, Hamburg, Germany).</s><s>Stained sections were examined by confocal microscopy using a Zeiss LSM Exciter confocal microscope and ZEN 2008 software (Carl Zeiss, Jena, Germany).</s><s>Sections for immunoperoxidase staining were prepared as detailed above.</s><s>Tissue peroxidases were blocked with 3% hydrogen peroxide in methanol prior to application of the primary antibodies.</s><s>Signal was developed using HRP-labeled donkey antirabbit secondary antibody (Dianova) and 3,3=-diaminobenzidine containing 0.3% hydrogen peroxide (Sigma-Aldrich); samples were processed synchronously with standardized incubation times to ensure comparability of the measurements.</s></p><p><s>Validation of sEH antibody.</s><s>Antibody specificity was verified by immunoblotting in sEH knockout tissue and by peptide blockade in rat kidney sections.</s><s>To this end, we performed Western blot analysis on total kidney homogenates from sEH-deficient mice and their respective controls.</s><s>Peptide blockade studies were conducted using the immunizing peptide (APrEST76223, Atlas Antibodies, Stockholm, Sweden).</s><s>sEH antibody was diluted in 5% nonfat dry milk in PBS and incubated at 37°C for 30 min with different amounts of blocking peptide prior to application to rat kidney sections.</s><s>Western blot analysis and immunostainings were performed as described above.</s></p><p><s>Renal tubule perfusion.</s><s>Freshly isolated cortical thick ascending limb segments of 10 male C57/BL6 mice (Charles River, Sulzfeld, Germany) were incubated with either 0.34% ethanol (control) or with 1 M 14,15-EET (Cayman Chemicals, Ann Arbor, MI) in 0.32% ethanol or 1 M 14,15-DHET (Cayman Chemicals) in 0.34% ethanol for 30 -40 min at 30°C in incubation solution (140 mmol/l NaCl, 0.4 mmol/l KH 2PO4, 1.6 mmol/l K2HPO4, 1 mmol/l MgCl2, 10 mmol/l Na-acetate, 1 mmol/l ␣-ketoglutarate, 1.3 mmol/l Ca-gluconate, 3.75 mg/ml glycine, 0.48 mg/ml trypsin inhibitor, 0.25 mg/ml DNase I, and 5 mg/ml albumin, at pH 7.4).</s><s>All chemicals were obtained from Merck (Darmstadt, Germany) unless indicated otherwise.</s><s>Preincubated cortical thick ascending limbs (cTALs) were then transferred into the bath on a heated microscope stage.</s><s>The bath was heated to 37°C, and continuous bath perfusion at 3-5 ml/min with control solution (140 mmol/l NaCl, 0.4 mmol/l KH 2PO4, 1.6 mmol/l K2HPO4, 1 mmol/l MgCl2, 5 mmol/l glucose, 1.3 mmol/l Cagluconate, at pH 7.4) was obtained by gravity perfusion.</s><s>Tubules were held and perfused by a concentric glass pipette system.</s><s>The perfusion pipette was double-barreled, and barrel 1 was used for voltage measurement and perfusion (perfusion rate 10 -20 nl/min; 7.6 Ϯ 0.3 m inner diameter) with control solution.</s><s>Barrel 2 was used for constant current injection (13 nA) and perfusion with low Cl Ϫ solution (28 mmol/l NaCl, 0.4 mmol/l KH2PO4, 1.6 mmol/l K2HPO4, 1 mmol/l MgCl2, 5 mmol/l glucose, 1.3 mmol/l Ca-gluconate, 51 mmol/l mannitol, 62 mmol/l NaSO4, at pH 7.4).</s><s>After an equilibration period under symmetric control conditions, first the basolateral and then the luminal solution was changed to low Cl Ϫ .</s><s>Cable equations were used to calculate transepithelial resistance Rte, as described previously <ref type="bibr" target="#b20">(21)</ref>.</s><s>Equivalent short-circuit current I=sc was calculated from Rte and Vte, according to Ohms law, for both conditions, respectively.</s><s>The percentage of I=sc under low Cl Ϫ in relation to the I=sc under high Cl Ϫ (Vmax) was calculated as the measure of Cl Ϫ affinity of the transporter <ref type="bibr" target="#b8">(9)</ref>.</s><s>The effects of the EET isomers on NKCC2 phosphorylation were determined using mouse kidney cell suspensions.</s><s>To this end, kidneys of adult male C57/BL6N mice were flushed with incubation solution to remove the blood.</s><s>Kidneys were subsequently incubated for 10 min in incubation solution containing 1 mg/ml collagenase 2 (Sigma-Aldrich) for collagenase digestion.</s><s>After complete digestion, the cells were pelleted by centrifugation at 1000 g for 10 min, collagenase solution was discarded, and the pellet resuspended in fresh incubation solution containing 100 nM dDAVP to induce NKCC2 phosphorylation.</s><s>Aliquots of the resulting cell sus- Analysis of published microarray data of kidney extracts from dDAVP-treated Brattleboro rats shows strong induction of sEH mRNA levels, as compared to vehicle-treated controls, whereas the mRNA abundance of the principal cytochrome P-450 monooxygenases, Cyp2c11, Cyp2c23, Cyp2j3, and Cyp2j10 are unaltered.</s><s>Cyp2j4 mRNA shows a modest decrease which, however, could not be reproduced by an alternative technology.</s><s>Data are derived from <ref type="bibr" target="#b50">(51)</ref> and are presented as x-fold of vehicle-treated controls.</s><s>*P Ͻ 0.05; n ϭ 3 per group.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effect of dDAVP on medullary expression of EET-metabolizing enzymes. Screening of Affymetrix microarray results</head><p><s>from kidney extracts of dDAVP-or vehicle-treated Brattleboro rats revealed constant mRNA levels for the CYP monooxygenases in CYP2C11, CYP2C23, CYP2J3, and Cyp2J10 (Table <ref type="table" target="#tab_0">1</ref>).</s><s>Abundance of CYP2J4 mRNA was reduced by 20% relative to the vehicle-treated controls (P Ͻ 0.05), but subsequent real-time PCR verification studies in a separate set of animals (n ϭ 5 per group) failed to confirm differential regulation (data not shown).</s><s>mRNA levels for sEH were significantly induced (ϩ145% relative to controls; P Ͻ 0.05) and in the real-time PCR verification studies (ϩ160 Ϯ 37%, P Ͻ 0.05).</s></p><p><s>Effect of dDAVP on renal-free EET tissue levels.</s><s>Mass spectrometry analysis of renal lipid levels in dDAVP-treated Brattleboro rats revealed a reduced abundance of 5,6-EET (12.8 Ϯ 3.2 ng/g vs. 35.7 Ϯ 9.5 ng/g; P Ͻ 0.05), 11,12-EET (16.7 Ϯ 3.3 ng/g vs. 38.4</s><s>Ϯ 9.7 ng/g; P Ͻ 0.05), and 14,15-EET (11.2 Ϯ 3 ng/g vs. 34.7 Ϯ 9.2 ng/g; P Ͻ 0.05) relative to controls.</s><s>Levels of the 8,9-isomer showed a strong trend toward reduced levels (17.4 Ϯ 4 ng/g vs. 44 Ϯ 13.4 ng/g; P ϭ 0.08) but failed to reach the level of statistical significance.</s><s>Values are given as ng EET/g wet tissue weight in dDAVP and vehicle-treated animals with n ϭ 7 to 8 animals per group (Fig. <ref type="figure" target="#fig_0">1</ref>).</s><s>It must be noted that 5,6-EET rapidly forms a lactone in aqueous solutions, which may differ from the parent molecule in its biological activity.</s><s>During the tissue processing for our mass spectrometry assay, this lactone is converted back to 5,6-EET.</s><s>Thus, the measured levels for the 5,6-EET regioisomer may be higher than the biologically active levels in the tissue.</s></p><p><s>We also determined the levels of the linoleic acid epoxides 9,10-EPOME (69 Ϯ 14 ng/g vs. 254 Ϯ 60 ng/g; P Ͻ 0.05) and 12,13-EPOME (36 Ϯ 11 ng/g vs. 166 Ϯ 44 ng/g; P Ͻ 0.05), as well as their respective diols 9,10-DIHOME [52 Ϯ 8.8 ng/g vs. 47 Ϯ 8.7 ng/g; P ϭ 0.7, not significant (n.s.)] and 12,13-DIHOME (85 Ϯ 25 ng/g vs. 56 Ϯ 14 ng/g; P ϭ 0.4 n.s.) in dDAVP-treated Brattleboro rats and control rats.</s><s>The ratios for 9,10-DIHOME and 9,10-EPOME (0.85 vs. 0.23; n ϭ 7 to 8 animals per group; P Ͻ 0.05) and 12,13-DIHOME and 12,13-EPOME (2.54 vs. 0.43; n ϭ 7 or 8 animals per group; P Ͻ 0.01) were significantly increased in the dDAVPtreated animals, thus demonstrating increased sEH enzyme activity (Fig. <ref type="figure">2</ref>).</s></p><p><s>Characterization of sEH antibody.</s><s>Specificity of the sEH antibody was verified by peptide blockade and by immunoblotting on kidney samples of sEH-deficient mice.</s><s>Preincubation of sEH antibody with the immunizing peptide caused a dose-dependent decrease in signal intensity in rat kidney sections.</s><s>Blockade was maximal at 10-fold excess of the blocking peptide (Fig. <ref type="figure">3A</ref>).</s><s>Western blot analysis of kidney homogenates from wild-type mice revealed the presence of a dominant sEH-immunoreactive band at 63 kDa, which was absent in the homogenates of the sEH-deficient mice.</s><s>An additional band was detected at 70 kDa.</s><s>However, this band was also present in the sEH-deficient mice and was, therefore, considered unspecific (Fig. <ref type="figure">3B</ref>).</s></p><p><s>Renal distribution of sEH.</s><s>Zonal distribution of sEH was analyzed on rat kidney homogenates isolated from cortex and outer and inner medulla.</s><s>Distribution of NKCC2 was determined in parallel and showed abundant signal in the outer medulla, weaker signal in the cortex, and absence of signal in the inner medulla, thus confirming the adequate separation of the kidney zones.</s><s>Western blot for sEH revealed a dominant immunoreactive band at ϳ63 kDa, which was present in all kidney zones.</s><s>Samples from the inner medulla contained additional sEH-immunoreactive products at 50 and 48 kDa, which probably represent splice variants of the enzyme (Fig. <ref type="figure">3C</ref>) <ref type="bibr" target="#b26">(27)</ref>.</s></p><p><s>Immunofluorescence labeling of rat and human kidney sections confirmed abundant expression of immunoreactive protein in all kidney zones (Figs.</s><s><ref type="figure" target="#fig_4">3-6</ref>).</s><s>In the cortex, strong cytosolic sEH signal was found in profiles of the macula densa, as indicated by the coexpression COX-2 (Fig. <ref type="figure" target="#fig_2">4, A-C</ref>).</s><s>Coexpression of sEH and COX-2 was further detected in a subset of cells in the cortical TAL (Fig. <ref type="figure" target="#fig_2">4, D-F</ref>), whereas the remaining TAL was devoid of staining.</s><s>Principal cells of the connecting tubule and the cortical collecting duct were identified by their expression of AQP2 and showed abundant sEH signal (Fig. <ref type="figure" target="#fig_2">4, G-I</ref>).</s><s>Triple labeling with the Na ϩ -Cl Ϫ -cotransporter NCC demonstrated the complete absence of sEH from the distal convoluted tubule (Fig. <ref type="figure" target="#fig_2">4I</ref>).</s><s>Profiles of the proximal tubule displayed subapical signal with intermediate intensity, which was localized directly below the megalin-immunoreactive brush-border membrane (Fig. <ref type="figure" target="#fig_2">4, J-L</ref>).</s><s>Signal intensity increased toward the end of the S3 segment and extended into the thin descending limb of the loop of Henle (Fig. <ref type="figure" target="#fig_3">5, A-C</ref>).</s><s>Profiles of the thin ascending limb of the loop of Henle stained positive as well (Fig. <ref type="figure" target="#fig_3">5, D-F</ref>).</s><s>Strong staining for sEH in the outer medulla was further detected in the collecting ducts, which were typically in close proximity with NKCC2-expressing profiles of the thick ascending limb, thus suggesting functional interaction (Fig. <ref type="figure" target="#fig_3">5, G-I</ref>).</s><s>Staining in the inner medulla was localized to tDLH, tALH, and to the principal cells of the inner medullary collecting duct, as indicated by the coexpression of AQP2 (Fig. <ref type="figure" target="#fig_3">5, J-L</ref> the distinction between the full-length protein and the shorter products, the observed signals in the inner medulla reflect the sum of the full-length protein and the shorter variants.</s></p><p><s>The renal vasculature, as identified by the expression of ␣-smooth muscle actin in myocytes and pericytes of the vascular wall, was devoid of sEH staining (Fig. <ref type="figure" target="#fig_4">6</ref>).</s><s>Studies in human kidney samples confirmed the expression in the macula densa and in the collecting duct using the sEH antibody validated in rodent tissue together with NKCC2 or AQP2 costaining (Fig. <ref type="figure" target="#fig_5">7</ref>).</s><s>mechanism on renal sEH expression were studied in dDAVPtreated Brattleboro rats.</s><s>Functional data for these animals demonstrating augmented urine concentration and induced levels of NKCC2 and aquaporin 2 have been reported before <ref type="bibr" target="#b16">(17,</ref><ref type="bibr" target="#b50">51)</ref>.</s><s>Immnuohistochemistry revealed increased sEH protein levels in the cortex and in the outer medulla of dDAVPtreated animals.</s><s>Here sEH signal was strongly increased in connecting tubules and in the cortical and outer medullary collecting ducts.</s><s>Protein levels in the inner medulla remained unchanged (Fig. <ref type="figure" target="#fig_7">8A</ref>).</s><s>Western blot analysis of total kidney homogenates confirmed increased levels of the 63 kDa (ϩ65 Ϯ 7% compared with controls; P Ͻ 0.05) and the 50 kDa (ϩ65 Ϯ 7% compared with controls; P Ͻ 0.05) variant of the protein in the dDAVP-treated animals (Fig. <ref type="figure" target="#fig_7">8, B and C</ref>).</s><s>Effect of EET regioisomers on TAL transport activity and NKCC2 phosphorylation.</s><s>The acute effects of the different EET regioisomers on the phosphorylation of NKCC2 were determined in murine kidney cell suspensions prestimulated with 100 nM dDAVP.</s><s>Incubation of these cell suspensions with the individual EET regioisomers resulted in a significant reduction of pNKCC2 abundance for 5,6-EET, 8,9-EET and 14,15-EET compared with the vehicle-treated controls (Ϫ35 Ϯ 14%, Ϫ53 Ϯ 8%, and Ϫ66 Ϯ 5%, respectively; P Ͻ 0.05).</s><s>In contrast, 11,12-EET had no effect (ϩ18 Ϯ 15%, P ϭ 0.5) (Fig. <ref type="figure" target="#fig_6">9</ref>).</s><s>To corroborate these results, we studied the effects of the 14,15-EET regioisomer in greater detail and also included the inactive metabolite 14,15-DHET.</s><s>Phosphorylation of NKCC2 functionally changes the transport current by changing NKCC2 membrane trafficking, as well as by changing its Cl Ϫ affinity, rate-limiting in the cortical TAL with already dilute luminal fluid <ref type="bibr" target="#b8">(9,</ref><ref type="bibr" target="#b21">22)</ref>.</s><s>To investigate the effect of 14,15-EET on TAL tubular transport, we, therefore, measured the equivalent short-circuit current I' sc under two Cl Ϫ concentrations, at 147 mmol/l to assess maximal transport velocity (V max ) of the transporter and at 30 mmol/l, a concentration close to the described EC 50 of NKCC2 for Cl Ϫ <ref type="bibr" target="#b21">(22)</ref>.</s><s>Freshly isolated cTAL were incubated with either vehicle (control), 1 mol/l 14,15 -EET or 1 mol/l 14,15-DHET for 30 -40 min.</s><s>After this preincubation period isolated perfused cTALs of the three groups, Control, 14,15-EET, and 14,15-DHET, showed the typical lumen positive transport I'sc.</s><s>Pretreatment with 14,15-EET reduced I=sc to 70% of the control I' sc under high Cl Ϫ concentrations and to ϳ30% under the low Cl Ϫ concentration, respectively (Fig. <ref type="figure" target="#fig_8">10A</ref>).</s><s>To address the question of whether 14,15-EET only reduces the total amount of NKCC2 in the plasma membrane, thereby shifting the curve in the scheme (Fig. <ref type="figure" target="#fig_8">10B</ref>) from 1 to 2, or also decreases its Cl Ϫ affinity (curve 3 in the scheme), we calculated the percentage of I=sc (low Cl Ϫ ) of the respective V max (147 Cl Ϫ ) values (Fig. <ref type="figure" target="#fig_8">10B</ref>).</s><s>resulted in a dose-dependent reduction of pNKCC2 levels compared with cell suspensions treated with 100 nM dDAVP and ethanol as vehicle (control).</s><s>Treatment with 1 M 14,15-DHET had no effect on the NKCC2 phosphorylation (Fig. <ref type="figure" target="#fig_8">10D</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Effect of chronic dDAVP treatment on renal sEH expression. The effects of a chronic activation of the urine-concentrating</head><p><s>Effect of sEH gene disruption on NKCC2 phosphorylation.</s><s>Analysis of outer medullary pNKCC2 abundance revealed greatly reduced levels in the sEH-deficient mice relative to the wild-type controls (Fig. <ref type="figure" target="#fig_9">11</ref>), whereas total NKCC2 abundance was unchanged (data not shown).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>The aim of the present study was to characterize the effects of AVP on the abundance and metabolism of EET isomers in the kidney.</s><s>We have demonstrated markedly reduced tissue levels of EET isomers along with an increased abundance of the principal EET-metabolizing enzyme sEH in connecting tubules and collecting ducts of AVP-treated Brattleboro rat kidneys compared with vehicle-treated controls.</s><s>EET isomers and AVP have been shown to exert opposing effects on essential renal sodium transporters.</s><s>In connecting tubule (CNT) and collecting duct (CD), AVP activated the amiloridesensitive epithelial sodium channel ENaC <ref type="bibr" target="#b4">(5,</ref><ref type="bibr" target="#b5">6)</ref>, whereas 14,15-EET acted as a potent inhibitor of ENaC transport activity <ref type="bibr" target="#b12">(13)</ref>.</s><s>In the TAL, AVP caused activation of NKCC2dependent ion transport, in part, by increasing its phosphorylation <ref type="bibr" target="#b45">(46)</ref>.</s><s>In the present study, we found a pronounced inhibitory effect of all EET regioisomers with the exception of 11   <ref type="bibr" target="#b22">(23)</ref> found no effect of 10 Ϫ8 M 5,6-EET on transport activity in isolated rat TAL segments.</s><s>However, the 5,6-EET concentration used in that study was well below the free tissue concentrations observed in our study and may, therefore, have been insufficient to inhibit NKCC2-dependent transport.</s><s>Opposing effects of AVP and EETs have further been described for the renal vasculature.</s><s>Here, AVP causes vasoconstriction either directly by activating vascular V 1 receptors or indirectly by its effects on epithelial V 2 receptors <ref type="bibr" target="#b7">(8,</ref><ref type="bibr" target="#b44">45,</ref><ref type="bibr" target="#b66">67)</ref>, whereas EETs may function as vasodilating mediators in afferent arterioles and interlobular arteries (reviewed in Ref. <ref type="bibr" target="#b29">30)</ref>.</s><s>The observed reduction of renal EET levels in response to AVP may, therefore, be instrumental for sodium retention and increase in renovascular resistance during AVP-mediated urine concentration.</s></p><p><s>Cellular sources and regulation of renal EET synthesis during antidiuresis have not been clarified satisfactorily in previous work.</s><s>The first rate-limiting step during the formation of EETs is the release of arachidonic acid from membrane phospholipids, which is typically catalyzed by a phospholipase A2 (PLA2) isoenzyme.</s><s>The identity of the PLA2 isoenzyme involved in the synthesis of EETs has not been elucidated.</s><s>However, in a previous study, we have shown that the calciumindependent isoform of PLA2 (iPLA2␤) is abundantly expressed in the connecting tubule and medullary collecting duct and that chronic stimulation with dDAVP led to a reduction of iPLA2␤ biosynthesis, with the assumed consequence of reduced AA release <ref type="bibr" target="#b50">(51)</ref>.</s><s>Since both connecting tubule and collecting duct have been identified as important sites for intrarenal EET production (65), reduced iPLA2 levels at these sites may likely have contributed to the reduced abundance of  EETs observed in the present study.</s><s>Alternative pathways for arachidonic acid release have been described, but their relevance for renal EET synthesis remains to be determined <ref type="bibr" target="#b15">(16,</ref><ref type="bibr" target="#b35">36)</ref>.</s><s>The next step in the biosynthesis of EETs is catalyzed by a CYP monooxygenase isoenzyme; however, on the basis of the results of microarray studies CYP monooxygenase abundance was not affected by AVP.</s><s>This finding argues against a relevant role of CYP monooxygenases as rate-limiting enzymes in EET metabolism under this condition.</s><s>Here, we have, however, identified an additional mechanism for the regulation of EET levels in response to AVP, which centrally involves the function of sEH.</s><s>So far, ample evidence has linked sEH to the pathophysiology of cardiovascular and renal disease, and inhibitors of sEH have been shown to exert antihypertensive and renoprotective effects <ref type="bibr" target="#b32">(33,</ref><ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b37">38,</ref><ref type="bibr" target="#b43">44,</ref><ref type="bibr" target="#b52">53,</ref><ref type="bibr" target="#b58">58)</ref>.</s><s>In spite of extensive studies performed on the renal expression of sEH, however, there is still no consensus regarding the intrarenal localization of the enzyme.</s><s>Earlier reports range from an exclusively vascular localization <ref type="bibr" target="#b74">(75)</ref> over interstitial <ref type="bibr" target="#b52">(53)</ref> to preferentially glomerular <ref type="bibr" target="#b37">(38)</ref> or tubular expression <ref type="bibr" target="#b32">(33)</ref>.</s><s>In our study, we found widespread distribution of the protein with expression in proximal tubules, ascending and descending thin limbs of the loop of Henle, the macula densa, and in CNT and CD, whereas glomeruli, medullary TAL and DCT, and vascular structures were devoid of staining.</s><s>Little is currently known regarding the function of sEH in individual nephron segments.</s><s>In the proximal tubule, 5,6-EET and 14,15-EET have been shown to inhibit sodium transport <ref type="bibr" target="#b28">(29,</ref><ref type="bibr" target="#b38">39,</ref><ref type="bibr" target="#b41">42,</ref><ref type="bibr" target="#b63">64)</ref>.</s><s>Expression of sEH in the apical membrane of proximal tubules may, therefore, serve to deactivate EETs in the tubular fluid to avoid uncontrolled inhibition of transport.</s><s>Another important finding of our study is the abundant expression of sEH in macula densa and cortical TAL and its colocalization with COX-2 at these sites.</s><s>COX-2-derived prostaglandins cause vasodilation of the afferent arteriole and, thereby, play an important role for the maintenance of glomerular filtration during impaired renal perfusion <ref type="bibr" target="#b23">(24)</ref>.</s><s>However, COX-2 is also capable of oxidizing 5,6-EET, and the resulting metabolites have been shown to cause vasoconstriction of the preglomerular vasculature <ref type="bibr" target="#b30">(31)</ref>.</s><s>sEH activity in the macula densa and the cortical TAL may, therefore, reduce local EET levels and may, thus, prevent the formation of vasoconstrictive metabolites.</s><s>Notably, we found high levels of sEH also in the inner medulla, where we and others had previously detected abundant COX-2 expression <ref type="bibr" target="#b11">(12,</ref><ref type="bibr" target="#b69">70,</ref><ref type="bibr" target="#b72">73)</ref>.</s><s>Again, sEH may serve to prevent the formation of EET metabolites with unwanted properties at this site.</s></p><p><s>The dDAVP-treated Brattleboro rats revealed elevated sEH levels in CNT and CD, which corresponds to the established localization of the AVP V 2 receptor <ref type="bibr" target="#b45">(46,</ref><ref type="bibr" target="#b49">50,</ref><ref type="bibr" target="#b60">60)</ref> and suggests a functional link between AVP signaling and sEH activation.</s><s>Although a mechanism for this link has so far not been explored, the analysis of the sEH promotor sequence revealed the presence of several putative cAMP-response elements in our hands.</s><s>AVP-dependent induction of sEH biosynthesis may, therefore, be mediated via the AVP V 2 receptor-dependent activation of adenylyl cyclase VI <ref type="bibr" target="#b56">(56)</ref>.</s><s>Other mediators that have been shown to regulate sEH biosynthesis and may interfere with AVP signaling include ANG II <ref type="bibr" target="#b31">(32,</ref><ref type="bibr" target="#b68">69,</ref><ref type="bibr" target="#b71">72,</ref><ref type="bibr" target="#b77">78)</ref>, steroid hormones <ref type="bibr" target="#b42">(43,</ref><ref type="bibr" target="#b55">55)</ref>, and PPAR␥ agonists <ref type="bibr" target="#b24">(25,</ref><ref type="bibr" target="#b46">47)</ref>.</s></p><p><s>The potential biological relevance of an AVP-dependent activation of sEH is illustrated by observations in several animal models for renal and cardiovascular disease.</s><s>Along this line, spontaneously hypertensive rats displayed increased renal sEH activity compared with their normotensive Wistar-Kyoto counterparts <ref type="bibr" target="#b75">(76)</ref>, along with elevated plasma levels of AVP <ref type="bibr" target="#b10">(11,</ref><ref type="bibr" target="#b13">14)</ref>, and an increased abundance of renal AVP receptors <ref type="bibr" target="#b65">(66)</ref>.</s><s>Hypertension in these animals could be effectively reduced by treatment with antagonists for AVP <ref type="bibr" target="#b62">(63)</ref> or sEH <ref type="bibr" target="#b34">(35)</ref>.</s><s>Parallel protective effects of antagonists for AVP and sEH have also been described for DOCA-salt-induced hypertension <ref type="bibr" target="#b9">(10,</ref><ref type="bibr" target="#b48">49,</ref><ref type="bibr" target="#b54">54)</ref>, systolic heart failure <ref type="bibr" target="#b43">(44)</ref>, or diabetic nephropathy <ref type="bibr" target="#b6">(7)</ref>.</s><s>On the basis of our findings, we, thus, suggest that the detrimental effects of AVP may, in part, be mediated by its effect on sEH synthesis and the resulting accelerated degradation of vasodilatory and transport-inhibiting EET.</s></p><p><s>In summary, we have shown that activation of AVP signaling causes upregulation of renal sEH biosynthesis and enzyme activity.</s><s>The resulting reduction of EET tissue levels may facilitate increased transport activity and renal vasoconstriction to promote antidiuresis, but it may as well render the kidney susceptible to insult.</s><s>Further characterization of the AVP-sEH-EET axis may, therefore, provide new targets for renoprotective therapeutic strategies.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 1 .</head><label>1</label><figDesc><div><p><s>Fig.1.</s><s>Effect of AVP V2 receptor analog desmopressin (dDAVP) treatment on outer medullary free epoxyeicosatrienoic acid (EET) levels in Brattleboro rats.</s><s>Quantification of outer medullary free EET concentrations reveals significantly lower levels of 5,6-EET, 11,12-EET, and 14,15-EET upon 5 ng/h dDAVP for 3 days compared with vehicle-treated controls.</s><s>8,9-EET reduction failed to be significant (P ϭ 0.08).</s><s>Data are expressed as means Ϯ SE; *P Ͻ 0.05; n ϭ 7 or 8 per group.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig. 2 .Fig. 3 .</head><label>23</label><figDesc><div><p><s>Fig. 2. Effect of dDAVP treatment on outer medullary levels of linoleic acid derivates in Brattleboro rats.</s><s>Quantification of outer medullary levels of epoxide (EPOME)-and dihydroxy (DIHOME)-derivatives of linoleic acid reveals an increased DIHOME/EPOME ratio; this suggests increased activity of soluble epoxide hydrolase (sEH) (61).</s><s>*P Ͻ 0.05; **P Ͻ 0.01; n ϭ 7 or 8 per group.</s></p></div></figDesc><graphic coords="4,76.49,71.72,186.18,161.41" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>Fig. 4 .</head><label>4</label><figDesc><div><p><s>Fig. 4. Localization of sEH protein in Sprague-Dawley rat kidney.</s><s>Representative micrographs documenting double labeling of rat kidney sections with rabbit anti sEH antibody (A, D, G, J) and cyclooxygenase 2 (COX-2; B and E) as a marker for the macula densa segment, the Na ϩ -Cl Ϫ -cotransporter NCC as a marker for the distal convoluted tubule (DCT; magenta in I), aquaporin 2 (AQP2) as a marker for the principal cells of the connecting tubule (CNT; H), and megalin as a marker for the proximal tubule (K).</s><s>In the merged color images (C, F, I, L), red signal indicates sEH, and green signals mark COX-2 (C and F), AQP2 (I), and megalin (L).</s><s>Magenta signal (I) marks NCC. Macula densa [between flanking lines in (C)] shows strong signal for sEH and COX-2 (A-C).</s><s>sEH and COX-2 are also coexpressed in a subset of TAL cells distant to the juxtaglomerular apparatus (JGA; D-F).</s><s>Abundant signal for sEH is present in the AQP2-immunoreactive CNT principal cells (G-I).</s><s>DCT profiles are negative for sEH (G-I).</s><s>Proximal convoluted tubule shows subapical sEH signal beneath megalin staining (J-L).</s><s>Immunofluorescence staining: bars 20 m.</s><s>Blue nuclei are stained by DAPI.</s><s>G denotes glomerulus in C; while * denotes TAL in F. Dashed line in I marks the transition from DCT (ϩ) to CNT (#).</s></p></div></figDesc><graphic coords="5,214.85,622.82,116.23,115.45" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>Fig. 5 .</head><label>5</label><figDesc><div><p><s>Fig. 5. Localization of sEH protein in Sprague-Dawley rat kidney (continued).</s><s>Representative micrographs documenting double labeling of rat kidney sections with rabbit anti sEH antibody (A, D, G, J) and megalin (B) as a marker for the proximal tubule (PT), Na-K-2Cl-cotransporter NKCC2 (E and H) as a marker for the thick ascending limb (TAL), and aquaporin 2 (AQP2; K) as a marker for the medullary collecting duct.</s><s>In the merged color images (C, F, I, L), red signal indicates sEH, and green signals mark megalin (C), NKCC2 (F and I), and AQP2 (L).</s><s>PT sEH signal is localized subapically (A-C).</s><s>Signal is stronger within terminal S3 and ensuing descending thin limb (DTL) portions (arrows in C) and continues to the ascending thin limb (ATL; ϩ in F) until its transition to the negative TAL (* in F and I).</s><s>Abundant sEH signal is present in the principal cells of the collecting duct in the outer (G-I) and inner medulla (J-L).</s><s>Double labeling with NKCC2 shows the close local association between sEH-expressing collecting ducts (# in I) and profiles of the TAL in the outer medulla (G-I).</s><s>In the inner medulla, sEH is abundantly expressed in DTL, ATL, and collecting ducts, with partial overlap to AQP2 in the latter (J-L).</s><s>Immunofluorescence staining: bars 20 m.</s><s>Blue nuclei are stained by DAPI.</s><s>The dashed line in F marks the transition from ATL to TAL.</s></p></div></figDesc><graphic coords="6,283.79,394.10,113.47,113.11" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>Fig. 6 .</head><label>6</label><figDesc><div><p><s>Fig. 6.</s><s>Localization of sEH protein in the renal vasculature.</s><s>Representative micrographs documenting double labeling of rat kidney sections with anti-sEH antibody (A, D, G, J) and ␣-smooth muscle actin (B, E, H, K; ␣-sma) as a marker for the vascular wall.</s><s>In the merged color images (C, F, I, L), red signal indicates sEH, and green signals mark ␣-sma.</s><s>There is complete separation of the two signals, demonstrating an absence of sEH from vascular smooth muscle and endothelial cells of afferent arterioles (A-C), arcuate vessels (D-F), vasa recta of outer (G-I), and inner medulla (J-L).</s><s>Immunofluorescence staining: bars 20 m.</s><s>Blue nuclei are stained by DAPI.</s><s>G denotes glomerulus, while * denotes afferent arteriole in C; ϩ indicates the lumen of an arcuate vein, and § indicates the lumen of an arcuate artery in F.</s></p></div></figDesc><graphic coords="7,121.79,552.32,129.37,129.19" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>Fig. 7 .</head><label>7</label><figDesc><div><p><s>Fig. 7. Localization of sEH protein in the human kidney.</s><s>Double labeling of human kidney sections with rabbit anti-sEH antibody (A, D, G) and antibodies against NKCC2 (B and E) or aquaporin 2 (AQP2; H).</s><s>In the merged color images (C, F, I), red signal indicates sEH, and green signals mark NKCC2 (C and F) and AQP2 (I).</s><s>Ample sEH protein is expressed in the macula densa (between flanking lines in (C), whereas the cells of the surrounding TAL are negative.</s><s>Strong staining is also present in outer and inner medullary collecting duct profiles.</s><s>Immunofluorescence staining: bars 20 m.</s><s>G denotes glomerulus in C, while * denotes TAL in F; and # shows the collecting ducts in F and I.</s></p></div></figDesc><graphic coords="8,282.83,70.82,117.67,117.67" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>Fig. 9 .</head><label>9</label><figDesc><div><p><s>Fig. 9. Effect of EET regioisomers on NKCC2 phosphorylation.</s><s>A: Western blots of murine kidney cell suspensions treated with 100 nM dDAVP as control (Ϫ) or with 100 nM dDAVP and 1 M 5,6-EET, 8,9-EET, 11,12-EET, or 14,15-EET (ϩ) for 30 min.</s><s>Bands show lower levels of phosphorylated NKCC2 (pNKCC2) after treatment with 5,6-EET, 8,9-EET, and 14,15-EET; total NKCC2 abundance was determined in parallel and serves as loading control.</s><s>B: Densitometric analysis of the signal intensity and normalization to total NKCC2 levels confirms reduced abundance of pNKCC2 after treatment with 5,6-EET, 8,9-EET, and 14,15-EET.</s><s>No effect is detectable following treatment with 11,12-EET.</s><s>Data are expressed as means Ϯ SE; **P Ͻ 0.01; n ϭ 8 -10 per group.</s><s>Samples were prepared from a total of six mice.</s></p></div></figDesc><graphic coords="9,335.51,439.28,196.83,179.23" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_7"><head>Fig. 8 .</head><label>8</label><figDesc><div><p><s>Fig. 8. Effect of chronic vasopressin V2 receptor activation on sEH protein expression in Brattleboro rats.</s><s>A: representative high-power micrographs showing sEH signal in the cortex (I, II), outer medulla (III, IV), and inner medulla of Brattleboro rats after vehicle (I, III, V; control) or dDAVP treatment (II, IV, VI; dDAVP).</s><s>Treated animals show a stronger accumulation of immunoreactive sEH in the cortex and outer medulla compared with controls.</s><s>Inner medullary sEH signals are not different.</s><s>Immunoperoxidase staining: bars 100 m; n ϭ 8 per group.</s><s>B: Western blot of kidney homogenates from Brattleboro rats treated with vehicle or dDAVP showing increased signal intensity for the 63-and 50-kDa sEH variants; ␤-actin served as a loading control.</s><s>C: densitometric analysis of the signal confirms increased total abundance of sEH in the treated animals.</s><s>Data are means Ϯ SE; *P Ͻ 0.05; n ϭ 8 per group.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_8"><head>Fig. 10 .</head><label>10</label><figDesc><div><p><s>Fig. 10.</s><s>Effects of 14,15-EET on TAL transport activity and NKCC2 phosphorylation.</s><s>A: summarized data of the equivalent short-circuit current I=sc of isolated perfused cTAL pretreated with vehicle (control; white bars), 1 M 14,15-EET (black bars), or 1 M 14,15-DHET (gray bars) under two symmetric Cl Ϫ concentrations, 30 mmol/l Cl Ϫ (30) and 147 mmol/l Cl Ϫ (147).</s><s>B: simplified scheme to illustrate enzyme kinetic like properties of NKCC2 (curve 1) with maximal transport rate (Vmax, dashed line).</s><s>Reduced number of NKCC2 in the membrane reduces Vmax with unchanged EC50 (curve 2).</s><s>Changes in Cl Ϫ affinity of NKCC2 lead to an additional shift of EC50 to higher Cl Ϫ concentrations (curve 3).</s><s>C: I=sc at low-chloride concentration expressed as a percentage of the respective Vmax values; the 55% reduction after 14,15-EET pretreatment shows a markedly reduced Cl Ϫ affinity.</s><s>Treatment with 14,15-DHET has no detectable effect on I=sc.</s><s>Electrophysiological data are means Ϯ SE; n ϭ 8, 9, and 8 for control, 14,15-EET, and 14,15-DHET, respectively.</s><s>*P Ͻ 0.05 control vs. 14,15-EET.</s><s>#P Ͻ 0.05 14,15-EET vs. 14,15-DHET.</s><s>D: Western blot of dDAVP-stimulated murine kidney cell suspensions showing a dose-dependent reduction of phosphorylated NKCC2 (pNKCC2) after treatment with 0.1 M and 1 M 14,15-EET compared with the vehicle-treated control.</s><s>Treatment of dDAVPstimulated kidney cell suspensions with 14,15-DHET has no effect.</s><s>Total NKCC2 abundance was determined in parallel and serves as a loading control.</s><s>Representative example of n ϭ 9 for vehicle-, EET-, and DHET, respectively.</s><s>Samples were prepared from a total of six mice.</s></p></div></figDesc><graphic coords="10,43.50,71.45,516.00,204.00" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_9"><head>Fig. 11 .</head><label>11</label><figDesc><div><p><s>Fig. 11.</s><s>Effect of sEH deficiency on outer medullary levels of phosphorylated NKCC2 (pNKCC2).</s><s>Representative low-(I and II) and high-(III and IV) power micrographs showing reduced levels of immunoreactive pNKCC2 in the outer medulla of sEH-deficient mice (II and IV; sEH-/-) compared with wild-type controls (I and II).</s><s>Immunoperoxidase staining: bars, 200 m for I and II, and 20 m for III and IV.</s><s>n ϭ 4 per group.</s></p></div></figDesc><graphic coords="10,43.79,590.30,123.19,91.27" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1 .</head><label>1</label><figDesc><div><p><s>Microarray analysis of dDAVP effects on outer medullary mRNA levels of soluble epoxide hydrolase and cytochrome P-450 monooxygenases</s></p></div></figDesc><table><row><cell>Gene Title</cell><cell>Gene Symbol</cell><cell>mRNA Accession</cell><cell>Probe Set ID</cell><cell>x-Fold of Control</cell><cell>P</cell></row><row><cell>Epoxide hydrolase 2, cytoplasmic</cell><cell>EPHX2</cell><cell>NM_022936</cell><cell>Rn.54495_at</cell><cell>2.45</cell><cell>0.04*</cell></row><row><cell>Cytochrome P-450, family 2, subfamily c, polypeptide 11</cell><cell>Cyp2c11</cell><cell>NM_019184</cell><cell>1387328_at</cell><cell>1.3</cell><cell>0.68</cell></row><row><cell>Cytochrome P-450, family 2, subfamily c, polypeptide 23</cell><cell>Cyp2c23</cell><cell>NM_031839</cell><cell>1367988_at</cell><cell>0.97</cell><cell>0.52</cell></row><row><cell>Cytochrome P-450, family 2, subfamily j, polypeptide 3</cell><cell>Cyp2j3</cell><cell>NM_175766</cell><cell>1370706_a_at</cell><cell>0.99</cell><cell>0.8</cell></row><row><cell>Cytochrome P-450, family 2, subfamily j, polypeptide 4</cell><cell>Cyp2j4</cell><cell>NM_023025</cell><cell>Rn.44992_at</cell><cell>0.78</cell><cell>0.003*</cell></row><row><cell>Cytochrome P-450, family 2, subfamily j, polypeptide 10</cell><cell>Cyp2j10</cell><cell>NM_001134980</cell><cell>Rn.34638_at</cell><cell>0.95</cell><cell>0.26</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">AJP-Renal Physiol• doi:10.1152/ajprenal.00062.2016 • www.ajprenal.org Downloaded from journals.physiology.org/journal/ajprenal (176.172.000.127) on May 17, 2022.</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>We thank F. Grams, K. Riskowsky, and C. Andrée for technical assistance and A. Drobbe for editorial support.</s></p></div>
			</div>

			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>GRANTS</head><p><s>These studies were supported by the Deutsche Forschungsgemeinschaft (FOR667 and FOR1368).</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Na ϩ -K ϩ (NH4 ϩ )-2Cl-cotransport in medullary thick ascending limb: control by PKA, PKC, and 20-HETE</title>
		<author>
			<persName><forename type="first">H</forename><surname>Amlal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Legoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vernimmen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Paillard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bichara</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">271</biblScope>
			<biblScope unit="page" from="C455" to="C463" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Arachidonic acid-metabolizing cytochrome P450 enzymes are targets of -3 fatty acids</title>
		<author>
			<persName><forename type="first">C</forename><surname>Arnold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Markovic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Blossey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wallukat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dechend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Konkel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Von Schacky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Luft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rothe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Schunck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="page" from="720" to="732" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Kidneyspecific inactivation of the megalin gene impairs trafficking of renal inorganic sodium phosphate cotransporter (NaPi-IIa)</title>
		<author>
			<persName><forename type="first">S</forename><surname>Bachmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Schlichting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Geist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mutig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Petsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bacic</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Wagner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kaissling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Biber</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Murer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Willnow</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="892" to="900" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Opposed effects of prostaglandin E2 on perfusion of rat renal cortex and medulla: interactions with the reninangiotensin system</title>
		<author>
			<persName><forename type="first">B</forename><surname>Badzynska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sadowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Physiol</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="1292" to="1302" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Vasopressin: a novel target for the prevention and retardation of kidney disease?</title>
		<author>
			<persName><forename type="first">L</forename><surname>Bankir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bouby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Ritz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Nephrol</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="223" to="239" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Vasopressin-V2 receptor stimulation reduces sodium excretion in healthy humans</title>
		<author>
			<persName><forename type="first">L</forename><surname>Bankir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Fernandes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bardoux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bouby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">G</forename><surname>Bichet</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="1920" to="1928" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Protein-and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and urea</title>
		<author>
			<persName><forename type="first">L</forename><surname>Bankir</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Roussel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Bouby</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">309</biblScope>
			<biblScope unit="page" from="F2" to="F23" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Short-term renal hemodynamic effects of tolvaptan in subjects with autosomal dominant polycystic kidney disease at various stages of chronic kidney disease</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">E</forename><surname>Boertien</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Meijer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>De Jong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Bakker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">S</forename><surname>Czerwiec</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Struck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Oberdhan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Shoaf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">B</forename><surname>Krasa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Gansevoort</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">84</biblScope>
			<biblScope unit="page" from="1278" to="1286" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Calcineurin and sorting-related receptor with A-type repeats interact to regulate the renal Na ϩ -K ϩ -2Cl Ϫ cotransporter</title>
		<author>
			<persName><forename type="first">A</forename><surname>Borschewski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Himmerkus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Boldt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">I</forename><surname>Blankenstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Mccormick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Lazelle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Willnow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Jankowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Plain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bleich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Ellison</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bachmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mutig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="107" to="119" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Time course of synergistic interaction between DOCA and salt on blood pressure: roles of vasopressin and hepatic osmoreceptors</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">L</forename><surname>Brooks</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Qi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Regul Integr Comp Physiol</title>
		<imprint>
			<biblScope unit="volume">291</biblScope>
			<biblScope unit="page" from="R1825" to="R1834" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Age-dependent regulation of renal vasopressin V1A and V2 receptors in rats with genetic hypertension: implications for the treatment of hypertension</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Burrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Risvanis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">G</forename><surname>Dean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Patel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Velkoska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">I</forename><surname>Johnston</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Hypertens</title>
		<imprint>
			<biblScope unit="page" from="3" to="13" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Key enzymes for renal prostaglandin synthesis: site-specific expression in rodent kidney (rat, mouse)</title>
		<author>
			<persName><forename type="first">V</forename><surname>Campean</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Theilig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Paliege</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Breyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bachmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">285</biblScope>
			<biblScope unit="page" from="F19" to="F32" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Role of cytochrome P450 epoxygenase in regulating renal membrane transport and hypertension</title>
		<author>
			<persName><forename type="first">J</forename><surname>Capdevila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Nephrol Hypertens</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="163" to="169" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Vasopressin in the rat with spontaneous hypertension</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">T</forename><surname>Crofton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Share</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">E</forename><surname>Shade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Allen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Tarnowski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Heart Circ Physiol</title>
		<imprint>
			<biblScope unit="volume">235</biblScope>
			<biblScope unit="page" from="H361" to="H366" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Interactions among prostaglandin E2, antidiuretic hormone, and cyclic adenosine monophosphate in modulating Cl Ϫ absorption in single mouse medullary thick ascending limbs of Henle</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">M</forename><surname>Culpepper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Andreoli</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="1588" to="1601" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Lipid droplets in activated mast cells-a significant source of triglyceride-derived arachidonic acid for eicosanoid production</title>
		<author>
			<persName><forename type="first">A</forename><surname>Dichlberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Schlager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">T</forename><surname>Kovanen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Schneider</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Pharmacol</title>
		<imprint>
			<biblScope unit="volume">785</biblScope>
			<biblScope unit="page" from="59" to="69" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Chronic activation of vasopressin V2 receptor signaling lowers renal medullary oxygen levels in rats</title>
		<author>
			<persName><forename type="first">A</forename><surname>Dietrich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Mathia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Kaminski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mutig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rosenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mrowka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bachmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Paliege</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Physiol</title>
		<imprint>
			<biblScope unit="volume">207</biblScope>
			<biblScope unit="page" from="721" to="731" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Determination of the dominant arachidonic acid cytochrome p450 monooxygenases in rat heart, lung, kidney, and liver: protein expression and metabolite kinetics</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>El-Sherbeni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Aboutabl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">N</forename><surname>Zordoky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Anwar-Mohamed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">O</forename><surname>El-Kadi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AAPS J</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="112" to="122" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Distribution of soluble epoxide hydrolase and of cytochrome P450 2C8, 2C9, and 2J2 in human tissues</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Enayetallah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>French</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Thibodeau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Grant</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Histochem Cytochem</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="447" to="454" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Soluble epoxide hydrolase regulates hematopoietic progenitor cell function via generation of fatty acid diols</title>
		<author>
			<persName><forename type="first">T</forename><surname>Fromel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Jungblut</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Trouvain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Barbosa-Sicard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Popp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Liebner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Dimmeler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Hammock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Fleming</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page">0</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Cation selectivity of the isolated perfused cortical thick ascending limb of Henle&apos;s loop of rabbit kidney</title>
		<author>
			<persName><forename type="first">R</forename><surname>Greger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pflügers Arch</title>
		<imprint>
			<biblScope unit="volume">390</biblScope>
			<biblScope unit="page" from="30" to="37" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Chloride activity in cells of isolated perfused cortical thick ascending limbs of rabbit kidney</title>
		<author>
			<persName><forename type="first">R</forename><surname>Greger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Oberleithner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Schlatter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Cassola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Weidtke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pflügers Arch</title>
		<imprint>
			<biblScope unit="volume">399</biblScope>
			<biblScope unit="page" from="29" to="34" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">P450 arachidonate metabolites mediate bradykinin-dependent inhibition of NaCl transport in the rat thick ascending limb</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Grider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Falcone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Kilpatrick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Ott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Jackson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Can J Physiol Pharmacol</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="91" to="96" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Cyclooxygenase-2 inhibition and renal physiology</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Harris</surname><genName>Jr</genName></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Cardiol</title>
		<imprint>
			<biblScope unit="volume">89</biblScope>
			<biblScope unit="page" from="10D" to="17D" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Soluble epoxide hydrolase: gene structure, expression and deletion</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">R</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Hammock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gene</title>
		<imprint>
			<biblScope unit="volume">526</biblScope>
			<biblScope unit="page" from="61" to="74" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">NO inhibits Na ϩ -K ϩ -2Cl Ϫ cotransport via a cytochrome P-450-dependent pathway in renal epithelial cells (MMDD1)</title>
		<author>
			<persName><forename type="first">H</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Podymow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zimpelmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">D</forename><surname>Burns</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">284</biblScope>
			<biblScope unit="page" from="F1235" to="F1244" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Identification and characterization of an ovary-selective isoform of epoxide hydrolase</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Hennebold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Perez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Vance</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Stouffer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Morisseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Hammock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">Y</forename><surname>Adashi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Reprod</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="968" to="975" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Interaction between P450 eicosanoids and nitric oxide in the control of arterial tone in mice</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">C</forename><surname>Hercule</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Schunck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Seringer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Leung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Weldon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Da Costa Goncalves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Luft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gollasch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arterioscler Thromb Vasc Biol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="54" to="60" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Signaling pathways in the biphasic effect of angiotensin II on apical Na/H antiport activity in proximal tubule</title>
		<author>
			<persName><forename type="first">P</forename><surname>Houillier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Chambrey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Achard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Froissart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Poggioli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Paillard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="1496" to="1505" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Epoxides and soluble epoxide hydrolase in cardiovascular physiology</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Imig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Rev</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="101" to="130" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Actions of epoxygenase metabolites on the preglomerular vasculature</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Imig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">G</forename><surname>Navar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Roman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Reddy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Falck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="2364" to="2370" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Imig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Capdevila</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Morisseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Hammock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="690" to="694" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Soluble epoxide hydrolase is a main effector of angiotensin II-induced hypertension</title>
		<author>
			<persName><forename type="first">O</forename><surname>Jung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Brandes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Schweda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Hammock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Busse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Fleming</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="759" to="765" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">P450-dependent arachidonic acid metabolism and angiotensin II-induced renal damage</title>
		<author>
			<persName><forename type="first">E</forename><surname>Kaergel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Honeck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Theuer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Shagdarsuren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Mullally</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Luft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Schunck</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="273" to="279" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Discovery of 2,8-diazaspiro[4.5]decane-based trisubstituted urea derivatives as highly potent soluble epoxide hydrolase inhibitors and orally active drug candidates for treating hypertension</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Kato</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fuchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Saburi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nishimura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yagi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Nakadera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Higashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Aoki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Bioorg Med Chem Lett</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="5975" to="5979" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Renal phospholipase C and diglyceride lipase activity in spontaneously hypertensive rats</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kawaguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Okamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Saito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yasuda</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="100" to="106" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Molecular physiology of water balance</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Knepper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">H</forename><surname>Kwon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Nielsen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="page" from="1349" to="1358" />
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Soluble epoxide hydrolase activity determines the severity of ischemia-reperfusion injury in kidney</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">Y</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Paik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Oh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">S</forename><surname>Lim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e37075</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Arachidonic acid metabolites inhibit the stimulatory effect of angiotensin II in renal proximal tubules</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Yamada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Endo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Horita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Yamazaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Shimizu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Seki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fujita</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertens Res</title>
		<imprint>
			<biblScope unit="volume">31</biblScope>
			<biblScope unit="page" from="2155" to="2164" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">J</forename><surname>Livak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Schmittgen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Methods</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="402" to="408" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 genedisrupted mice</title>
		<author>
			<persName><forename type="first">A</forename><surname>Luria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Weldon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Kabcenell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Ingraham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Matera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gill</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Morisseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Newman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Hammock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="page" from="2891" to="2898" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">An epoxygenase metabolite of arachidonic acid mediates angiotensin IIinduced rises in cytosolic calcium in rabbit proximal tubule epithelial cells</title>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">T</forename><surname>Madhun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Goldthwait</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Mckay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Hopfer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">G</forename><surname>Douglas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">88</biblScope>
			<biblScope unit="page" from="456" to="461" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">The response of corticotropin and adrenal steroids to desmopressin stimulation in patients with various forms of hypercortisolism</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">I</forename><surname>Marova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">P</forename><surname>Goncharov</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Kolesnikova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Arapova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Lapshina</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hormones</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="243" to="250" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Soluble epoxide hydrolase is a susceptibility factor for heart failure in a rat model of human disease</title>
		<author>
			<persName><forename type="first">J</forename><surname>Monti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Paskas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Heinig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schulz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Gosele</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Heuser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fischer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Schmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schirdewan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Gross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Hummel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Maatz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Patone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Saar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Vingron</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Weldon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Lindpaintner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Hammock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rohde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dietz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Cook</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Schunck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Luft</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hubner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="529" to="537" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Renal vasoconstriction by vasopressin V1a receptors is modulated by nitric oxide, prostanoids, and superoxide but not the ADP ribosyl cyclase CD38</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Moss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">E</forename><surname>Kopple</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Arendshorst</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">306</biblScope>
			<biblScope unit="page" from="F1143" to="F1154" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Vasopressin V2 receptor expression along rat, mouse, and human renal epithelia with focus on TAL</title>
		<author>
			<persName><forename type="first">K</forename><surname>Mutig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Paliege</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Jons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Muller-Esterl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bachmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">293</biblScope>
			<biblScope unit="page" from="F1166" to="F1177" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">PPAR␥ agonists inhibit vasopressin-mediated anion transport in the MDCK-C7 cell line</title>
		<author>
			<persName><forename type="first">C</forename><surname>Nofziger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>Brown</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Harrington</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bisi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Ashton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">P</forename><surname>Maurio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Kalsi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">A</forename><surname>West</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Baines</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Blazer-Yost</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">297</biblScope>
			<biblScope unit="page" from="F55" to="F62" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Regulation of soluble epoxide hydrolase (sEH) in mice with diabetes: high glucose suppresses sEH expression</title>
		<author>
			<persName><forename type="first">A</forename><surname>Oguro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Fujita</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Imaoka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Drug Metab Pharmacokinet</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="438" to="445" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Effect of nonpeptide vasopressin receptor antagonists on developing, and established DOCA-salt hypertension in rats</title>
		<author>
			<persName><forename type="first">H</forename><surname>Okada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Suzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Kanno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Saruta</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Hypertens</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="469" to="483" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Expression of vasopressin V1a and V2 receptor messenger ribonucleic acid in the liver and kidney of embryonic, developing, and adult rats</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">L</forename><surname>Ostrowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">S</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>3rd Knepper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Lolait</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">133</biblScope>
			<biblScope unit="page" from="1849" to="1859" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Group VIA phospholipase A2 is a target for vasopressin signaling in the thick ascending limb</title>
		<author>
			<persName><forename type="first">A</forename><surname>Paliege</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Roeschel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Neymeyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Seidel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Daigeler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mutig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Mrowka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">R</forename><surname>Ferreri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Wilson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Himmerkus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bleich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bachmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">302</biblScope>
			<biblScope unit="page" from="F865" to="F874" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Hypoxia-inducible factor-2␣-expressing interstitial fibroblasts are the only renal cells that express erythropoietin under hypoxia-inducible factor stabilization</title>
		<author>
			<persName><forename type="first">A</forename><surname>Paliege</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Rosenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bondke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Sciesielski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Shina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Heyman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Flippin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Arend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Klaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bachmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="312" to="318" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<monogr>
		<title level="m" type="main">Expression and role of soluble epoxide hydrolase in renal tissue of two kidneys one clip hypertension rats model</title>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">J</forename><surname>Pan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><forename type="middle">F</forename><surname>Tao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Q</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">F</forename><surname>Guan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Wang</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title/>
	</analytic>
	<monogr>
		<title level="j">Beijing Da Xue Xue Bao</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="820" to="826" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Changes in Fos expression in various brain regions during deoxycorticosterone acetate treatment: relation to salt appetite, vasopressin mRNA and the mineralocorticoid receptor</title>
		<author>
			<persName><forename type="first">L</forename><surname>Pietranera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">E</forename><surname>Saravia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Mcewen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Lucas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Johnson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Nicola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neuroendocrinology</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="396" to="406" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Differential regulation of soluble epoxide hydrolase by clofibrate and sexual hormones in the liver and kidneys of mice</title>
		<author>
			<persName><forename type="first">F</forename><surname>Pinot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Grant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Spearow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">G</forename><surname>Parker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Hammock</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Pharmacol</title>
		<imprint>
			<biblScope unit="volume">50</biblScope>
			<biblScope unit="page" from="501" to="508" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Adenylate cyclase 6 determines cAMP formation and aquaporin-2 phosphorylation and trafficking in inner medulla</title>
		<author>
			<persName><forename type="first">T</forename><surname>Rieg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Tang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Murray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Schroth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">A</forename><surname>Insel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Fenton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Hammond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Vallon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="2059" to="2068" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">P-450 metabolites of arachidonic acid in the control of cardiovascular function</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Roman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Physiol Rev</title>
		<imprint>
			<biblScope unit="volume">82</biblScope>
			<biblScope unit="page" from="131" to="185" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Renal and cardiovascular actions of 20-hydroxyeicosatetraenoic acid and epoxyeicosatrienoic acids</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Roman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">G</forename><surname>Maier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">W</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">R</forename><surname>Harder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Alonso-Galicia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Pharmacol Physiol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="855" to="865" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Cytochrome P-450-dependent metabolism of arachidonic acid in the kidney of rats with diabetes insipidus</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sarkis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mori</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kohzuki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Verbalis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">W</forename><surname>Cowley</surname><genName>Jr</genName></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">J</forename><surname>Roman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">289</biblScope>
			<biblScope unit="page" from="F1333" to="F1340" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Differential distribution of the vasopressin V receptor along the rat nephron during renal ontogeny and maturation</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Sarmiento</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Ehrenfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Anazco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Reyes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Troncoso</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Figueroa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Muller-Esterl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">B</forename><surname>Gonzalez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Kidney Int</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="487" to="496" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Targeted disruption of soluble epoxide hydrolase reveals a role in blood pressure regulation</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">R</forename><surname>Schmelzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Kubala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Newman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Eiserich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Hammock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Sinal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Miyata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tohkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Nagata</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Bend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">J</forename><surname>Gonzalez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="504" to="540" />
			<date type="published" when="2000">2005. 2000</date>
		</imprint>
	</monogr>
	<note>J Biol Chem</note>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">Attenuation of spontaneous hypertension in rats by a vasopressin antagonist</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">D</forename><surname>Sladek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Blair</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sterling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Mangiapane</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Hypertension</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="506" to="512" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Effects of epoxyeicosatrienoic acids on 86Rb uptake in renal epithelial cells</title>
		<author>
			<persName><forename type="first">R</forename><surname>Staudinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Escalante</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Schwartzman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Abraham</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cell Physiol</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="69" to="74" />
			<date type="published" when="1994">1994</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Low Na intake suppresses expression of CYP2C23 and arachidonic acid-induced inhibition of ENaC</title>
		<author>
			<persName><forename type="first">P</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Lin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Babilonia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Jin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kemp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Nasjletti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">291</biblScope>
			<biblScope unit="page" from="F1192" to="F1200" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Alterations of renal vasopressin V1A and V2 receptors in spontaneously hypertensive rats</title>
		<author>
			<persName><forename type="first">A</forename><surname>Tahara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Tsukada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Tomura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Wada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kusayama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Ishii</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yatsu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Uchida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Taniguchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Tanaka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pharmacology</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="106" to="112" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">Vasopressin constricts outer medullary descending vasa recta isolated from rat kidneys</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Turner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Pallone</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">272</biblScope>
			<biblScope unit="page" from="F147" to="F151" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Soluble epoxide hydrolase inhibitors reduce the development of atherosclerosis in apolipoprotein e-knockout mouse model</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ulu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Morisseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Inceoglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Fiehn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Hammock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Weiss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Cardiovasc Pharmacol</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="314" to="323" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Intrarenal cytochrome P-450 metabolites of arachidonic acid in the regulation of the nonclipped kidney function in two-kidney, one-clip Goldblatt hypertensive rats</title>
		<author>
			<persName><forename type="first">A</forename><surname>Walkowska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Skaroupkova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Huskova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Vanourkova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">C</forename><surname>Chabova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Tesar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Kramer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Falck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Imig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Kompanowska-Jezierska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sadowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Cervenka</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hypertens</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="582" to="593" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Upregulation of juxtaglomerular NOS1 and COX-2 precedes glomerulosclerosis in fawnhooded hypertensive rats</title>
		<author>
			<persName><forename type="first">W</forename><surname>Weichert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Paliege</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Provoost</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bachmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">280</biblScope>
			<biblScope unit="page" from="F706" to="F714" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Renal Na ϩ -K ϩ -Cl Ϫ cotransporter activity and vasopressin-induced trafficking are lipid raft-dependent</title>
		<author>
			<persName><forename type="first">P</forename><surname>Welker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Bohlick</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Mutig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Salanova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kahl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Schluter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Blottner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ponce-Coria</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Gamba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Bachmann</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">295</biblScope>
			<biblScope unit="page" from="F789" to="F802" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Hormonal and cardiovascular responses to DDAVP in man</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Lightman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Leadbeater</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Endocrinol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="89" to="96" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Regulation of cyclooxygenase-2 expression in renal medulla by tonicity in vivo and in vitro</title>
		<author>
			<persName><forename type="first">T</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Schnermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Briggs</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">277</biblScope>
			<biblScope unit="page" from="F1" to="F9" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Effects of prostaglandin E2 and I2 on renal cortical and medullary blood flow in rabbits</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ueda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Soejima</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tsuruta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ikegami</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Int Pharmacodyn Ther</title>
		<imprint>
			<biblScope unit="volume">282</biblScope>
			<biblScope unit="page" from="108" to="117" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Vascular localization of soluble epoxide hydrolase in the human kidney</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">B</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Morisseau</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Hammock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Olson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Kroetz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Weiss</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol Renal Physiol</title>
		<imprint>
			<biblScope unit="volume">286</biblScope>
			<biblScope unit="page" from="F720" to="F726" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Huse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Adler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Graham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Ma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">C</forename><surname>Zeldin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Kroetz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Pharmacol</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="1011" to="1020" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Regulation of cyclooxygenase expression by vasopressin in rat renal medulla</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">Z</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Sanchez</forename><surname>Lopez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Mckanna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Harris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Endocrinology</title>
		<imprint>
			<biblScope unit="volume">145</biblScope>
			<biblScope unit="page" from="1402" to="1409" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage</title>
		<author>
			<persName><forename type="first">X</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yamamoto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Newman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">H</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Watanabe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Hammock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Stewart</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Pollock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Pollock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Imig</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Soc Nephrol</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="1244" to="1253" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
